TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Omesh K. Bharti
  2. Vaccines and delivery technologies
  3. Monday, 14 September 2009
Dear Friends, It is a great pleasure to know that now Virorav has also come out with the intradermal option (attachment). This will be a further boost to the intradermal ARV campaign in India to controll rabies. After Rabipur, Abhyrab and Indirav, this will be the fourth drug offering a low-cost intradermal option in India. Regards, Dr. Omesh BhartiM.B.B.S., D.H.M., M.A.E. (Epidemiology)Directorate of Health Safety and Regulation, Himachal Pradesh+91-9418120302[][/email]; [email][/email]
TechNet Admin Accepted Answer
Dear Sir, Please correct the name Indirav to INDIRAB which is thecorrect brandname of the rabies vaccine manufactured by us. Thank you. Regards, Dr.G.V.J.A.Harshavardhan Director - RVDP Genome Valley, Shameerpet, Hyderabad - 500 078. A.P. India. Tel.: +91 40 2348 0567 Fax: +91 40 2348 0560
Omesh K. Bharti Accepted Answer
Dear Sir, Thanks for pointing out this mistake, actually it was a slip of finger as V and B are side by side on the typing board. Thanks Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Directorate of Health Safety and Regulation, Himachal Pradesh+91-9418120302[][/email]; [email][/email]

There are no replies made for this post yet.
Be one of the first to reply to this post!